// App-Quantinova.ai

: Effect of Ljpc-401 (synthetic human hepcidin) on Iron Parameters in Healthy Adults

Researchers

Presenter

  • John Porter

Principal Investigators

  • Kris Kowdley

  • Ali Taher

  • Jeffrey Vacirca

  • Zancong Shen

  • Steve Chen

  • Lakhmir Chawla

  • George Tidmarsh

Medical Centers

  • Research Haematology Department, University College London, London, United Kingdom

  • Swedish Medical Center, Seattle, WA

  • Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon

  • New York Cancer and Blood Specialists, New York, NY

  • La Jolla Pharmaceutical Company, San Diego, CA

Locations

  • United Kingdom

  • United States

  • Lebanon

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • LJPC 401

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Pharmacokinetics

  • Pharmacodynamics

  • Double Blind/Blinded

  • Single Ascending Dose

  • Multiple Arm

  • Controlled

  • Dose Escalation

  • Cohort

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved